Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells

Autor: Daniele Fina, R Caruso, E Calabrese, Roberto Testi, I Monteleone, S. Bellinvia, F Pallone, L Franchi, G. Monteleone, P. Vavassori, G.C. Naccari
Rok vydání: 2005
Předmět:
Male
Apoptosis
Protein Tyrosine Phosphatase
Non-Receptor Type 11

Protein tyrosine phosphatase
Non-Receptor Type 6
RNA interference
Epidermal growth factor receptor
Phosphorylation
RNA
Small Interfering

Mesalamine
Settore MED/12 - Gastroenterologia
Gene knockdown
Tumor
Blotting
Protein Tyrosine Phosphatase
Non-Receptor Type 6

Intracellular Signaling Peptides and Proteins
ErbB Receptors
Gene Expression Regulation
Neoplastic

surgical procedures
operative

Receptor
Epidermal Growth Factor

Enzyme Activation
Humans
Immunoprecipitation
Cell Line
Tumor

Cell Proliferation
Protein Tyrosine Phosphatases
Blotting
Western

RNA Interference
Adenocarcinoma
Colorectal Neoplasms
Western
Receptor
Biology
Small Interfering
Non-Receptor Type 11
Cell Line
Dephosphorylation
Gene silencing
Molecular Biology
Neoplastic
Epidermal Growth Factor
Cell Biology
digestive system diseases
Gene Expression Regulation
Cell culture
Immunology
Cancer research
biology.protein
RNA
Protein Tyrosine Phosphatase
Zdroj: Cell death and differentiation. 13(2)
ISSN: 1350-9047
Popis: Recent studies have suggested that 5-aminosalicylic acid (5-ASA) inhibits colorectal cancer (CRC) development. However, the mechanism underlying the antineoplastic effect of 5-ASA remains unknown. We here examined the effect of 5-ASA on epidermal growth factor receptor (EGFR) activation, a pathway that triggers mitogenic signals in CRC cells. We show that 5-ASA inhibits EGFR activation, through a mechanism that does not rely on CRC cell death induction. 5-ASA enhances the activity, but not expression, of phosphorylated (p)-EGFR-targeting phosphatases (PTPs), and treatment of cells with PTP inhibitors abrogates the 5-ASA-mediated EGFR dephosphorylation. Both SH-PTP1 and SH-PTP2 interact with EGFR upon 5-ASA treatment. However, knockdown of SH-PTP2 but not SH-PTP1 by small interference RNAs prevents the 5-ASA-induced EGFR dephosphorylation. Finally, we show that 5-ASA attenuates p-EGFR in ex vivo organ cultures of CRC explants. Data indicate that 5-ASA disrupts EGFR signalling by enhancing SH-PTP2 activity, and suggest a mechanism by which 5-ASA interferes with CRC growth.
Databáze: OpenAIRE